Secondary Sclerosing Cholangitis: a Review of Recent Literature

被引：30
作者：
Brooling J. [1 ]
Leal R. [2 ]
机构：
[1] Division of Gastroenterology, University of Arizona, Tucson, AZ
[2] Division of Gastroenterology, Southern Arizona VA Hospital, 3601 S 6th Ave, Tucson, 85723, AZ
来源：
Current Gastroenterology Reports | 2017年 / 19卷 / 9期
关键词：
Biliary stricture; Cholangitis; Critically ill patient; Obstructive jaundice; Secondary sclerosing cholangitis;
D O I：
10.1007/s11894-017-0583-8
中图分类号：
学科分类号：
摘要：
Purpose of Review: Secondary sclerosing cholangitis is an emerging entity. Yet, because of the low incidence and varying etiologies of this disease, the literature is not robust. There are mainly case reports and small studies evaluating the disease. Our aim in this review is to bring the reader up to date with recent literature on secondary sclerosing cholangitis including the disease presentation, course, prognosis, and treatment options. Recent Findings: Numerous case reports have been published the last 5 years on secondary sclerosing cholangitis. We have divided them into infectious, drug-induced, ischemic, obstructive, and autoimmune etiologies. The bulk of the literature describes secondary sclerosing cholangitis in the critically ill patient. Summary: Secondary sclerosing cholangitis due to drugs or autoimmune causes seem to have the best prognosis. However, causes such as critical illness seem to have worse outcomes. © 2017, US Government (outside the USA).
引用
收藏
相关论文
共 27 条
  • [1] Hubers L.M., Beuers U., How to diagnose immunoglobulin G4-associated cholangitis: the jack-of-all-trades in the biliary tract, Viszeralmedizin, 31, 3, pp. 185-188, (2015)
  • [2] Wiencke K., Boberg K.M., Current consensus on the management of primary sclerosing cholangitis, Clin Res Hepatol Gastroenterol, 35, 12, pp. 786-791, (2011)
  • [3] Imam M.H., Talwalkar J.A., Lindor K.D., Secondary sclerosing cholangitis: pathogenesis, diagnosis, and management, Clin Liver Dis, 17, 2, pp. 269-277, (2013)
  • [4] Chang W.-T., Lin N.-C., Hsia C.-Y., Liu C.-S., Tsai H.-L., Loong C.-C., Liver transplantation for a renal transplantation recipient with secondary sclerosing cholangitis by choledochoduodenal fistula, Asian J Surg, 35, 1, pp. 49-52, (2012)
  • [5] Gromski M.A., Fogel E.L., Vuppalanchi R., Secondary Sclerosing cholangitis from spontaneous choledochoduodenal fistula, Clin Gastroenterol Hepatol, 15, 3, pp. e71-e72, (2017)
  • [6] Frei P., Misselwitz B., Prakash M.K., Schoepfer A.M., Prinz Vavricka B.M., Mullhaupt B., Et al., Late biliary complications in human alveolar echinococcosis are associated with high mortality, World J Gastroenterol, 20, 19, pp. 5881-5888, (2014)
  • [7] Gudnason H.O., Bjornsson H.K., Gardarsdottir M., Thorisson H.M., Olafsson S., Bergmann O.M., Et al., Secondary sclerosing cholangitis in patients with drug-induced liver injury, Dig Liver Dis, 47, 6, pp. 502-507, (2015)
  • [8] Lo R.S.C., Krishnamoorthy R., Freeman J.G., Austin A.S., Cholestasis and biliary dilatation associated with chronic ketamine abuse: a case series, Singap Med J, 52, 3, pp. e52-e55, (2011)
  • [9] Turkish A., Luo J.J., Lefkowitch J.H., Ketamine abuse, biliary tract disease, and secondary sclerosing cholangitis, Hepatol Baltim Md, 58, 2, pp. 825-827, (2013)
  • [10] El Hajj I.I., Malik S.M., Alwakeel H.R., Shaikh O.S., Sasatomi E., Kandil H.M., Celecoxib-induced cholestatic liver failure requiring orthotopic liver transplantation, World J Gastroenterol, 15, 31, pp. 3937-3939, (2009)
123